In this podcast Euretina President, Mr Alistair Laidlaw and Euretina EVP Dara Conlon explore the highlights of this year’s congress which is on track to be the biggest and most exciting meeting yet!
In this episode, journalist Ramadan Younis and his executive producer Simon Cox tell us about their far-reaching BBC documentary. “Blind Faith” exposes the international practice of defrauding patients of Retinitis Pigmentosa with false hopes of treatment or cure with little or no evidence of efficacy. They are joined by Prof Robert McLaren of the University of Oxford, who consulted on the documentary and evaluated the scientific claims being made by bad actors in the programme.
In this episode, we’re going to dig into the subject of this year’s Ophtalmologica lecture which will be delivered on the Saturday afternoon at this year’s congress in Amsterdam. Professor Maximilan Pfau (Switzerland) is a clinician with a specialism in AMD and Inherited Retinal diseases in the Department of Ophthalmology at the University Eye Hospital, Basel. He’s joined by Editor in Chief of the Ophthalmologica Journal; Professor Martin Zinkernagel (Switzerland).
In this episode, we head to Asia to hear from colleagues in Japan, Singapore and South Korea about their experiences treating PCV and Pachychoroid in different populations. The podcast is chaired by Prof Taiji Sakamoto (Japan) and Prof Seung-Young Yu (South Korea) who are joined by Prof Gemmy Cheung (Singapore) and Prof Adrian Koh (Singapore).
In this podcast, we hear from Euretina Keynote Bertil Damato (UK/SWEDEN) about his upcoming talk on OncoVR at the 2023 Euretina Congress. He is joined by colleague Carl Groenewald (UK) and Heinrich Heimann (Chair – UK).
In this podcast, we’ll be hearing about an exciting new event taking place in Amsterdam at the Euretina Congress in October; the inaugural Euretina Innovation Summit (EIS). Kourous Rezaei and Anat Loewenstein – two members of the organising committee – will discuss the programme and motivation behind the event with chair Frank G Holz.
In this podcast, we’ll explore two areas in the subspecialty of myopia: Aude Couturier will share her expertise in macular holes and Dr Yves Lachkar will discuss glaucoma in highly myopic patients. Chaired by David Gaucher and Jost Jonas.
In this episode, Editor in Chief at Ophthalmologica, Professor Martin Zinkernagel discusses two featured papers from Euretina’s official journal. The first paper discussed covers choroiditis and the second covers effective treatment regimen in macular degeneration. Faculty are Dr Jeannette Ossewaarde-van Norel and Evianne de Groot (University Medical Center Utrecht) and Mathis Thibaud, Red Cross University Hospital, Lyon.
In this episode, we explore how to diagnose and treat intraocular lymphoma with a panel of leading retinal surgeons and oncologists. Dr Hibba Quhill chairs the discussion with Professors Carlos Pavesio and Mandeep Sagoo from Moorfields Eye Hospital, London.
In this episode, we will hear all of the tips and tricks to success when looking to submit your research to Ophthalmologica. Faculty: Martin Zinkernagel (Ophthalmologica editors, SWITZERLAND) and Marco Casola (Karger, SWITZERLAND). Chaired by Jonathan McCrea.
In this episode, Edoardo Midena (Italy) chairs a discussion with four leading experts in Diabetic Retinopathy from across the world: Jakob Grauslund (Denmark), Carol Cheung (Hong Kong), Enrico Borrelli (Italy) and Daniel Ting (Singapore).
In this episode, Siegfried Priglinger (Germany) and Roxane Hillier (UK) take a look at treatment for macula-off RRD. They’re joined by David Yorston (Scotland) and Julian Klaas (Germany) and will ask – how do we best define “macula-off” and when should we start treatment?
Treating rare diseases can sometimes be challenging due a the lack of literature. In this episode, Carlos Pavesio (UK) asks leading experts Moncef Khairallah (TUNISIA) and Sara Touhami (FRANCE) about their approaches to the diagnosis and treatment of Acute Retinal Necrosis (ARN).
In this podcast, David Steel (UK) tells Alistair Laidlaw (UK) what he’s learned from zeroing in on individual patient data and how factors like posture and hole size affect his decision-making in the treatment of macular holes.
In this podcast, Mark Penessi (USA) is joined by Isabelle Audo (FRANCE) and Bart Leroy (BELGIUM) to discuss the impact of Luxturna and how gene therapy products will affect the treatment of inherited retinal diseases (IRD) in the future.
Secretariat Address
European Society of Retina Specialists
Ground Floor, The Apex Building
Blackthorn Road
Sandyford Business Park
Co Dublin, D18 H6K2
Phone:+353 1 2100092
Email: [email protected]
Newsletter Sign up
Follow us
© EURETINA 2022 All rights reserved